These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17420026)

  • 1. Analysis of recent pharmaceutical regulatory documents on analytical method validation.
    Rozet E; Ceccato A; Hubert C; Ziemons E; Oprean R; Rudaz S; Boulanger B; Hubert P
    J Chromatogr A; 2007 Jul; 1158(1-2):111-25. PubMed ID: 17420026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--Part I.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Chiap P; Cohen N; Compagnon PA; Dewé W; Feinberg M; Lallier M; Laurentie M; Mercier N; Muzard G; Nivet C; Valat L
    J Pharm Biomed Anal; 2004 Nov; 36(3):579-86. PubMed ID: 15522533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical analysis of several analytical method validation strategies in the framework of the fit for purpose concept.
    Bouabidi A; Rozet E; Fillet M; Ziemons E; Chapuzet E; Mertens B; Klinkenberg R; Ceccato A; Talbi M; Streel B; Bouklouze A; Boulanger B; Hubert P
    J Chromatogr A; 2010 May; 1217(19):3180-92. PubMed ID: 19733857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in validation, risk and uncertainty assessment of bioanalytical methods.
    Rozet E; Marini RD; Ziemons E; Boulanger B; Hubert P
    J Pharm Biomed Anal; 2011 Jun; 55(4):848-58. PubMed ID: 21237607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodologies for the transfer of analytical methods: a review.
    Rozet E; Dewé W; Ziemons E; Bouklouze A; Boulanger B; Hubert P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2214-23. PubMed ID: 19144574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data.
    Ermer J; Ploss HJ
    J Pharm Biomed Anal; 2005 Apr; 37(5):859-70. PubMed ID: 15862659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by design compliant analytical method validation.
    Rozet E; Ziemons E; Marini RD; Boulanger B; Hubert P
    Anal Chem; 2012 Jan; 84(1):106-12. PubMed ID: 22107128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using tolerance intervals in pre-study validation of analytical methods to predict in-study results. The fit-for-future-purpose concept.
    Rozet E; Hubert C; Ceccato A; Dewé W; Ziemons E; Moonen F; Michail K; Wintersteiger R; Streel B; Boulanger B; Hubert P
    J Chromatogr A; 2007 Jul; 1158(1-2):126-37. PubMed ID: 17420025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analytical validation in compendium methods].
    Kaniwa N; Matsuda R; Ishibashi M
    Eisei Shikenjo Hokoku; 1993; (111):141-2. PubMed ID: 7920558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key aspects of analytical method validation and linearity evaluation.
    Araujo P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2224-34. PubMed ID: 18929516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it really necessary to validate an analytical method or not? That is the question.
    Rambla-Alegre M; Esteve-Romero J; Carda-Broch S
    J Chromatogr A; 2012 Apr; 1232():101-9. PubMed ID: 22099221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tests for robustness of biomedical and pharmaceutical analytic methods].
    Vander Heyden Y
    Verh K Acad Geneeskd Belg; 2003; 65(1):47-73. PubMed ID: 12802896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies.
    Geng D; Shankar G; Schantz A; Rajadhyaksha M; Davis H; Wagner C
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):364-75. PubMed ID: 15963677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in trace analysis of pharmaceutical genotoxic impurities.
    Liu DQ; Sun M; Kord AS
    J Pharm Biomed Anal; 2010 Apr; 51(5):999-1014. PubMed ID: 20022442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The validation of methods for regulatory purposes in the control of residues.
    Gowik P
    J Chromatogr A; 2009 Nov; 1216(46):8051-8. PubMed ID: 19595356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of capability indices in the framework of analytical methods validation.
    Bouabidi A; Ziemons E; Marini R; Hubert C; Talbi M; Bouklouze A; Bourichi H; El Karbane M; Boulanger B; Hubert P; Rozet E
    Anal Chim Acta; 2012 Feb; 714():47-56. PubMed ID: 22244136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and analysis of analytical method transfer studies.
    Schwenke JR; O'Connor DK
    J Biopharm Stat; 2008; 18(5):1013-33. PubMed ID: 18781533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of application.
    Hubert P; Nguyen-Huu JJ; Boulanger B; Chapuzet E; Cohen N; Compagnon PA; Dewé W; Feinberg M; Laurentie M; Mercier N; Muzard G; Valat L; Rozet E
    J Pharm Biomed Anal; 2008 Nov; 48(3):760-71. PubMed ID: 18768284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical method transfer: new descriptive approach for acceptance criteria definition.
    de Fontenay G
    J Pharm Biomed Anal; 2008 Jan; 46(1):104-12. PubMed ID: 17961955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.